| 000 | 01506 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512222723.0 | ||
| 264 | 0 | _c19841218 | |
| 008 | 198412s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1984.tb02451.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerpooten, G A | |
| 245 | 0 | 0 |
_aThe pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cAug 1984 |
||
| 300 |
_a183-93 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCilastatin |
| 650 | 0 | 4 |
_aCreatinine _xmetabolism |
| 650 | 0 | 4 |
_aCyclopropanes _xblood |
| 650 | 0 | 4 |
_aDipeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImipenem |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aThienamycins _xblood |
| 700 | 1 | _aVerbist, L | |
| 700 | 1 | _aBuntinx, A P | |
| 700 | 1 | _aEntwistle, L A | |
| 700 | 1 | _aJones, K H | |
| 700 | 1 | _aDe Broe, M E | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 18 _gno. 2 _gp. 183-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1984.tb02451.x _zAvailable from publisher's website |
| 999 |
_c6592925 _d6592925 |
||